| MR编号 | ES/V/0163/001 |
|---|
| 药品名称 | Wellplus Flavoured Tablets |
|---|
| 活性成分 | - febantel 150.0 mg
- praziquantel embonate 50.0 mg
- pyrantel embonate 144.0 mg
|
|---|
| 剂型 | Tablet |
|---|
| 上市许可持有人 | Divasa-Farmavic S.A.
Ctra. Sant Hipolit
Km 71 PO Box 79
08503 Gurb-Vic
Spain |
|---|
| 参考成员国 - 产品名称 | Spain (ES) |
|---|
| 互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
Wellplus Flavoured Tablets for Dogs - Germany (DE)
Wellplus - Belgium (BE)
Wellplus - Netherlands (NL)
- Ireland (IE)
Wellplus Flavoured Tablets - Portugal (PT)
- Greece (GR)
- Poland (PL)
Wellplus flavoured tablets for dogs - Bulgaria (BG)
- Romania (RO)
- Slovakia (SK)
|
|---|
| 许可日期 | 2013/10/24 |
|---|
| 最近更新日期 | 2020/06/22 |
|---|
| 药物ATC编码 | - QP52AA30 combinations of quinoline derivatives and related substances
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|